Roy Choudhury, Subhasree

Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. [electronic resource] - Investigational new drugs Dec 2010 - 812-24 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1573-0646

10.1007/s10637-009-9324-7 doi


Angiogenesis Inducing Agents--metabolism
Apoptosis--drug effects
Benzenesulfonates--pharmacology
Caspase 3--metabolism
Cell Cycle--drug effects
Cell Proliferation--drug effects
Cell Shape--drug effects
Cell Survival--drug effects
Cyclin-Dependent Kinase Inhibitor p21--metabolism
Down-Regulation--drug effects
Drug Synergism
Flow Cytometry
Gene Amplification--drug effects
Genistein--pharmacology
Humans
Mitochondria--drug effects
Myeloid Cell Leukemia Sequence 1 Protein
Neuroblastoma--drug therapy
Niacinamide--analogs & derivatives
Phenylurea Compounds
Proto-Oncogene Proteins c-bcl-2--metabolism
Proto-Oncogene Proteins c-myc--genetics
Pyridines--pharmacology
Signal Transduction--drug effects
Sorafenib
Telomerase--metabolism
Treatment Outcome
Tumor Suppressor Protein p53--metabolism
Up-Regulation--drug effects
bcl-2-Associated X Protein--metabolism